Myovant Sciences Ltd. Quarterly Income Tax Expense (Benefit) in USD from Q1 2016 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Myovant Sciences Ltd. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2016 to Q4 2022.
  • Myovant Sciences Ltd. Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $1.21M, a 307% increase year-over-year.
  • Myovant Sciences Ltd. Income Tax Expense (Benefit) for the twelve months ending December 31, 2022 was $21.5M, a 968% increase year-over-year.
  • Myovant Sciences Ltd. annual Income Tax Expense (Benefit) for 2021 was $5.05M, a 1402% increase from 2020.
  • Myovant Sciences Ltd. annual Income Tax Expense (Benefit) for 2020 was $336K, a 55.8% decline from 2019.
  • Myovant Sciences Ltd. annual Income Tax Expense (Benefit) for 2019 was $761K, a 59.9% increase from 2018.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $21.5M $1.21M +$909K +307% Oct 1, 2022 Dec 31, 2022 10-Q 2023-01-26
Q3 2022 $20.6M $8.11M +$8.26M Jul 1, 2022 Sep 30, 2022 10-Q 2022-10-26
Q2 2022 $12.3M $8.16M +$7.25M +796% Apr 1, 2022 Jun 30, 2022 10-Q 2022-07-27
Q1 2022 $5.05M $3.99M +$3.04M +319% Jan 1, 2022 Mar 31, 2022 10-K 2022-05-11
Q4 2021 $2.01M $296K +$1.45M Oct 1, 2021 Dec 31, 2021 10-Q 2023-01-26
Q3 2021 $560K -$149K -$15K -11.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 $575K $911K +$239K +35.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2021 $336K $952K +$890K +1435% Jan 1, 2021 Mar 31, 2021 10-K 2022-05-11
Q4 2020 -$554K -$1.15M -$1.35M -704% Oct 1, 2020 Dec 31, 2020 10-Q 2022-01-26
Q3 2020 $791K -$134K -$329K -169% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-26
Q2 2020 $1.12M $672K +$359K +115% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-28
Q1 2020 $761K $62K -$181K -74.5% Jan 1, 2020 Mar 31, 2020 10-K 2022-05-11
Q4 2019 $942K $191K +$191K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 $751K $195K +$107K +122% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $644K $313K +$168K +116% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $476K $243K +$637K Jan 1, 2019 Mar 31, 2019 10-K 2021-05-11
Q4 2018 -$161K $0 +$213K Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 -$374K $88K +$353K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$727K $145K -$940K -86.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $213K -$394K -$280K -246% Jan 1, 2018 Mar 31, 2018 10-K 2020-05-18
Q4 2017 $493K -$213K -$242K -834% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 $735K -$265K -$273K -3413% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $1.01M $1.09M +$1.08M +36067% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$74K -$114K -$114K Jan 1, 2017 Mar 31, 2017 10-K 2019-05-24
Q4 2016 $40K $29K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-13
Q3 2016 $8K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $3K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $0 Feb 3, 2016 Mar 31, 2016 10-K 2018-06-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.